KMPH - KemPharm, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
14.21M
Enterprise Value 3
86.18M
Trailing P/E
N/A
Forward P/E 1
-5.16
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.24
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
7.52
Enterprise Value/EBITDA 6
-3.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3-85.98%
S&P500 52-Week Change 325.78%
52 Week High 32.8200
52 Week Low 30.2650
50-Day Moving Average 30.4214
200-Day Moving Average 30.7536

Share Statistics

Avg Vol (3 month) 3923.42k
Avg Vol (10 day) 31.83M
Shares Outstanding 539.35M
Float 24.51M
% Held by Insiders 111.35%
% Held by Institutions 122.18%
Shares Short (Dec 30, 2019) 4932.81k
Short Ratio (Dec 30, 2019) 41.2
Short % of Float (Dec 30, 2019) 44.67%
Short % of Shares Outstanding (Dec 30, 2019) 42.57%
Shares Short (prior month Nov 28, 2019) 4653.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -206.47%
Operating Margin (ttm)-219.79%

Management Effectiveness

Return on Assets (ttm)-99.58%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)11.46M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.89M
Net Income Avi to Common (ttm)-23.67M
Diluted EPS (ttm)-0.8560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.52M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)80.07M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.83
Book Value Per Share (mrq)-2.18

Cash Flow Statement

Operating Cash Flow (ttm)-35.64M
Levered Free Cash Flow (ttm)-23.2M